Not a Lexis Advance subscriber? Try it out for free.


Mealey's PI/Product Liability - New Jersey Appeals Court Affirms Exclusion Of 2 Experts In 3,231 Accutane Cases

JERSEY CITY, N.J. - A New Jersey state appeals court on Jan. 17 affirmed the exclusion of two plaintiff experts opinions for "methodological defects," a ruling that the trial court applied to 3,231 other cases alleging that the acne drug Accutane caused plaintiffs to develop inflammatory bowel disease (In Re: Accutane Litigation, No. A-4952-16T1, N.J. Super., App. Div., 2020 N.J. Super. Unpub. LEXIS 123).
Find full version on lexis Advance®